# Hemopatch Performance Evaluation: A Prospective Observational Registry

> **NCT03392662** · — · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 621 (actual)

## Conditions studied

- Dura Mater Nick Cut or Tear
- Hemostatis
- Air Leakage
- Body Fluid Leakage

## Interventions

- **DEVICE:** Hemopatch

## Key facts

- **NCT ID:** NCT03392662
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-29
- **Primary completion:** 2019-01-28
- **Final completion:** 2019-01-28
- **Target enrollment:** 621 (ACTUAL)
- **Last updated:** 2022-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03392662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03392662, "Hemopatch Performance Evaluation: A Prospective Observational Registry". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03392662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*